Sanara MedTech Inc. — Director's Dealing 2020

Feb 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2020-02-10

Reporting Person: McNeil Michael D. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-10	Common Stock	J	2540	—	Disposed	8097	Direct
2020-02-10	Common Stock	J	8097	—	Disposed	0	Direct

Footnotes

F1: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 2,540 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock.

F2: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 8,097 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock.